Yung Shin Reports April 2026 Revenue of NT$694 Million, Down 1.5% Year-on-Year
Yung Shin (stock code: 3705) announced its revenue for April 2026, totaling NT$693.85 million (approximately US$21.3 million), a decrease of 1.5% compared to the same period last year. The company operates in the biotechnology and healthcare industry.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 13:01 (5h 1m after Collected)
Yung Shin, a company listed under stock code 3705, reported its revenue for April 2026. The total revenue for the month was NT$693.85 million, which is equivalent to NT$694 million. This figure represents a 1.5% decrease compared to the revenue generated in April 2025. Yung Shin operates within the biotechnology and healthcare industry.
FAQ
What was Yung Shin's revenue in April 2026?
Yung Shin's revenue in April 2026 was NT$693.85 million.
How does Yung Shin's April 2026 revenue compare to the previous year?
The revenue decreased by 1.5% compared to April 2025.
What industry does Yung Shin operate in?
Yung Shin operates in the biotechnology and healthcare industry.
What is Yung Shin's stock code?
Yung Shin's stock code is 3705.